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Abstract
Background: Over the last decade, kinases have emerged as attractive therapeutic targets for a number
of different diseases, and numerous high throughput screening efforts in the pharmaceutical community
are directed towards discovery of compounds that regulate kinase function. The emerging utility of
systems biology approaches has necessitated the development of multiplex tools suitable for proteomic-
scale experiments to replace lower throughput technologies such as mass spectroscopy for the study of
protein phosphorylation. Recently, a new approach for identifying substrates of protein kinases has applied
the miniaturized format of functional protein arrays to characterize phosphorylation for thousands of
candidate protein substrates in a single experiment. This method involves the addition of protein kinases
in solution to arrays of immobilized proteins to identify substrates using highly sensitive radioactive
detection and hit identification algorithms.
Results: To date, the factors required for optimal performance of protein array-based kinase substrate
identification have not been described. In the current study, we have carried out a detailed
characterization of the protein array-based method for kinase substrate identification, including an
examination of the effects of time, buffer compositions, and protein concentration on the results. The
protein array approach was compared to standard solution-based assays for assessing substrate
phosphorylation, and a correlation of greater than 80% was observed. The results presented here
demonstrate how novel substrates for protein kinases can be quickly identified from arrays containing
thousands of human proteins to provide new clues to protein kinase function. In addition, a pooling-
deconvolution strategy was developed and applied that enhances characterization of specific kinase-
substrate relationships and decreases reagent consumption.
Conclusion: Functional protein microarrays are an important new tool that enables multiplex analysis of
protein phosphorylation, and thus can be utilized to identify novel kinase substrates. Integrating this
technology with a systems biology approach to cell signalling will help uncover new layers in our
understanding of this essential class of enzymes.
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Background
Eukaryotes have devoted approximately two percent of
their genome to kinases, highlighting the importance of
protein kinase function. Protein kinases are involved in
numerous cellular processes, and aberrant kinase activity
has been directly implicated in the etiology of a wide spec-
trum of human pathologies. In recent years, several
kinase-directed drugs, including Gleevec®, Iressa®, Hercep-
tin® and Avastin®, were approved to treat human diseases
[1]. Currently, more than 50 protein kinase drug candi-
dates are in clinical trials to treat diseases including can-
cer, chronic inflammation, metabolic disorders, and
neurodegenerative disease. The importance of protein
phosphorylation in global regulation of cellular processes
is apparent from estimates that at least one third of all
proteins are phosphorylated [2]. For the vast majority of
these proteins, however, the protein kinase(s) responsible
for their phosphorylation is not known. In addition, the
function of many protein kinases is completely unknown
or has been poorly characterized. Despite their central role
in health and disease, the identification of protein kinase
substrates remains a significant challenge. Techniques
that advance our knowledge about the substrates of spe-
cific kinases will certainly aid in our understanding of this
biologically essential class of protein enzymes.
A growing number of methods to identify substrates of
protein kinases are available. Most commonly, proteins
from cells are isolated either from gels, by immunoprecip-
itation, or by metal affinity chromatography, and the
phosphorylated sequences are determined by mass spec-
trometry [3-5]. Kinase-substrate relationships have also
been determined through the use of enzyme inhibitors,
functional knockouts and analogue sensitive kinase alle-
les combined with mass spectrometry. There are limita-
tions inherent to these approaches, however, such as
functional redundancy, poor characterization of enzyme-
inhibitor specificity, and lack of sensitivity due to under-
representation of low abundance proteins in these
screens. In addition, mass spectrometry-based approaches
often require considerable amounts of time and a high
level of technical expertise to complete assays, operate
instrumentation, and perform data analysis. The use of
phospho-specific antibodies against consensus phosphor-
ylation sites has been helpful in addressing some of these
issues, but the consensus sequence information or high
quality phospho-specific antibodies are not available for
many discovery efforts.
In vitro based platforms using purified components offer
solutions to some of the limitations of mass spectrometry-
based approaches for protein kinase substrate identifica-
tion. For example, the use of peptide arrays in substrate
screens has been valuable for defining consensus phos-
phorylation sites for many protein kinases. However, it is
very difficult to predict which cellular proteins are in fact
substrates of protein kinases based solely on short pri-
mary sequence information, and using this data to iden-
tify  bona fide kinase substrates is often problematic.
Experiments have demonstrated that the ability of a
kinase to modify a protein at a specific site is influenced
by its structural context, including post-translational
modifications such as glycosylation [6-8], localized
sequential "priming" phosphorylations [9], inhibitory
sequences [10], secondary structure and solvent accessi-
bility [11]. For these reasons, using arrays of full-length
but denatured proteins to screen for kinase substrates, as
recently described by Feilner et al using arrays of dena-
tured Arabidopsis proteins [12], has significant limita-
tions, Solution-based assays using purified proteins that
have been expressed, purified, and demonstrate func-
tional activity can overcome some of these limitations but
can be costly to achieve on a large scale.
Proof-of-principal for the use of arrays of native or func-
tional proteins for kinase substrate profiling was
described by MacBeath and Schreiber [13]. Although this
study utilized arrays of only a few proteins, it demon-
strated some of the advantages that functional protein
arrays offer over existing assays. For example, arrays con-
taining thousands of proteins can be prepared with simi-
lar amounts of protein to rapidly establish kinase-
substrate relationships with limited concentration-based
artefacts. Second, the identity of the substrates is known
immediately following the assay since full-length proteins
are used and the position of each protein on the array is
known. Third, the probability that a phosphorylated
structured protein revealed in an array experiment is
indeed a cellular target of the kinase should be much
higher than candidate substrates identified from experi-
ments based on peptides. Lastly, because arrays may con-
tain up to thousands of proteins, target selectivity is
quickly addressed with minimal amounts of reagent.
Recently, a seminal study by Ptacek et al. profiled the activ-
ity for 87 purified yeast protein kinases against a pro-
teome array containing over 4000 proteins expressed and
purified from S. cerevisiae [14]. The approach successfully
identified thousands (4,192) of phosphorylation events
mapping to 1,325 different substrate proteins. The inte-
gration of these results with multiple data types has also
led to new proposals regarding yeast protein kinase inter-
action networks. More recently, Boyle et al. used high-
content human protein microarrays to identify the actin-
regulatory protein cortactin, a protein that is upregulated
in several cancers, as a novel substrate of the Abl and Abl-
related gene (Arg) nonreceptor tyrosine kinases [15].
These investigators went on to show that Abl-family
kinases target cortactin as an effector of cytoskeletal rear-
rangements in response to PDGF.BMC Biotechnology 2008, 8:22 http://www.biomedcentral.com/1472-6750/8/22
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In the current study, a detailed characterization of the pro-
tein microarray kinase-substrate identification assay is
presented. Arrays of human proteins are used, and critical
experimental parameters are investigated to address opti-
mal assay performance. We show that the kinase-substrate
phosphorylation microarray assay reconstitutes enzyme-
substrate interactions observed in solution-based assays
using a set of solution-validated protein kinase-substrate
pairs. Results are also presented that show that these
arrays can be used to quickly identify novel substrates of
human protein kinases on functional human protein
arrays containing thousands of highly purified proteins
and that pooling-deconvolution strategies can be
employed to rapidly identify specific kinase-substrate
relationships.
Results and Discussion
Solution validation of kinase-substrate interactions
Measuring phosphorylation of proteins by kinases in
solution-based assays may be the most common means of
confirming that a protein is indeed a substrate for a partic-
ular kinase. Consequently, substrate phosphorylation
assays using predominantly full-length proteins on pro-
tein arrays were compared to results generated in solution
assays for a number of commercially available kinase-sub-
strate pairs in order to determine the accuracy of the array-
based method. Kinase-substrate reactions were first per-
formed in solution to confirm that the protein kinases
indeed phosphorylated their intended substrates. This
involved mixing the protein kinases with the substrate
proteins in the presence of 33Pγ-ATP, incubating the sam-
ples at 30°C, resolving the proteins on SDS-page gels and
using a phosphorimager to detect substrate phosphoryla-
tion in the presence of kinase. A panel of 24 kinase-sub-
strate interactions comprising 14 different protein kinases
and 18 substrates was defined as the test set to evaluate the
ability to replicate the protein substrate phosphorylation
observed in solution on protein arrays (Table 1).
Table 1: Kinase-substrate pairs.
Solution Assay Protein Array Assay
Z_Score
Upstream Kinases Substrates (Signal/Background) -BSA +BSA
CaMKII Tau Protein 16.01 15.00 10.1
CDK5/p35 Tau Protein 28.24 18.80 6.5
CK2 pTEN 67.65 12.80 18.6
ERK2(MAPK) 4EBP/PHAS-1 3.85 6.10 9.6
ERK2(MAPK) Elk-1 Fusion Protein 8.17 17.00 20
ERK2(MAPK) Tau Protein 3.34 24.10 19.4
GSK3beta GST-Axin 33.63 1.40 2.4
JNK1 c-Jun 1–79 6.84 19.20 103.3
MAP2K6(MKK6) MAPK12 Inactive 20.45 0.90 0.1
MAP2K6(MKK6) MAPK14, Inactive 42.02 12.50 23.6
MAPK14 (p38alpha) 4EBP/PHAS-1 3.58 9.90 17.5
MAPK14 (p38alpha) ATF2 (aa 19–96) 6.48 22.60 25.5
MAPK14 (p38alpha) MAPKAP-K2 Inactive 13 13.90 19.4
MAPK14 (p38alpha) MAPKAP-K3 Inactive 6.21 10.70 22.4
MAPK14 (p38alpha) MAPKAP-K5, Inactive 5.07 5.40 2.4
MKK4/SKK1 MAPK12 Inactive 17.43 1.80 7.7
MKK4/SKK1 MAPK8 (JNK1) Inactive 23.17 2.90 0.7
MKK4/SKK1 MAPK9 (JNK2) Inactive 6.61 0.90 5.9
p38β2/SAPK2b2 MAPKAP-K3 Inactive 12.63 3.40 9.4
PDK1 AKT2 Inactive 6.33 4.30 3.1
PKA ATF2 (aa 19–96) 8.34 3.40 0.7
PKA Tau Protein 12.66 33.90 4.6
ROKα/ROCK-II MYPT1 (654–880) 51.54 14.40 23
RPS6KA3(RSK2) Estrogen Receptor-α 9.08 0.40 2.7
A set of 24 kinase-substrate interactions comprising 14 different protein kinases and 18 substrates was defined as the test set for benchmarking 
protein microarray results against solution phase assays. Solution phase reactions were run for each of these pairs in the presence of 33P-ATP. After 
1 hour, reactions were terminated by the addition of sample buffer and run on SDS-PAGE gels. Gels were subsequently dried, exposed to a 
phosphoscreen, and imaged in a Cyclone phosphoimager. Pixel intensity data from the resultant high resolution images was extracted and used to 
calculate the reported signal/background values. Protein microarray assays were run by incubating arrays with exogenous kinase in the presence of 
33P-ATP. After 60 minutes, arrays were washed, dried, exposed to a phosphoscreen, and imaged using a Cyclone phosphoimager. Pixel intensity 
data from the resultant high resolution images was extracted using GenePix software, and used to calculate the reported Z-Scores.BMC Biotechnology 2008, 8:22 http://www.biomedcentral.com/1472-6750/8/22
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Kinase-substrate interactions on protein arrays
Eighteen protein substrates were printed on modified
glass slides using a standard contact-type quill pin arrayer.
Purified protein kinases were added to the arrays in the
presence of 33Pγ-ATP, incubated at 30°C for different peri-
ods of time and rigorously washed to remove free kinase
and ATP. Images and data were acquired using a phos-
phorimager and standard microarray data acquisition
software (Figure 1). Protein kinases immobilized at
defined locations on the array facilitated mapping of sub-
strates by defining reference spots within the array image
(Figure 1, positive controls). When 33Pγ-ATP is added to
the arrays, these protein kinases autophosphorylate on
the surface and generate a radioactive signal upon detec-
tion. An example of a protein kinase-substrate interaction
is shown in Figure 1. The Rho-associated protein kinases
are known upstream regulators of myosin phosphatase
target subunit 1 (MYPT1) and control smooth muscle
contractility by negatively regulating its activity [16,17].
Significant signal for MYPT1 is observed only in the pres-
ence of Rho-associated coiled coil containing protein
kinase 2 (ROCKII). No signal is observed for MYPT1 on
the negative control slide (ATP alone). The performance
of the 24 kinase-substrate pairs was assessed in a similar
fashion on protein arrays using two protocols that were
distinguished primarily by the absence or presence of
bovine serum albumin (BSA) included in the blocking
and probing buffers. Eighteen kinase-substrate interac-
tions were observed using a protocol that included BSA
(slide blocking and kinase incubation steps both contain
BSA). Images of substrates phosphorylated by p38α and
ROCKII are shown in Figure 2a. Note that significant sig-
nals were observed only in the presence of kinase (ATP
only versus Kinase + ATP). This is consistent with the
results of the solution assays for these same kinase-sub-
strate pairs (Figure 2b).
Six of the kinase-substrate interactions in the test set were
not observed on the arrays using the standard protocol
when a static Z-Score threshold of 3.0 was applied, where
Microarray kinase substrate identification assay Figure 1
Microarray kinase substrate identification assay. A schematic of the experimental procedure used for kinase substrate 
identification on ProtoArray® is shown on the left. Representative slide images and enlarged regions show autophosphorylation 
of printed landmark kinase spots and a specific example of substrate phosphorylation for ROCKII kinase.
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the Z-Score represents the number of standard deviations
above the median signal value for all protein features
present on the array. BSA is included at a relatively high
concentration (10 mg/ml) in the standard array kinase-
substrate assay in order to block non-specific interactions,
but was not included in the solution phase assays used to
develop the test set. Eighteen kinase-substrate interactions
were observed using an array assay protocol that did not
contain any BSA, with 16 interactions overlapping with
those observed in the BSA protocol when a Z-Score thresh-
old of ≥3.0 was applied (Table 1). Several kinase-substrate
interactions exhibited significantly different signals
depending on the protocol that was used. For example,
the signals for Protein Kinase A (PKA) phosphorylation of
Tau protein were approximately eight-fold greater in the
absence of BSA (Figure 2c). Conversely, the signal for Map
Kinase Kinase 6 (MKK6) phosphorylation of p38α was
approximately 18-fold greater in the presence of BSA (Fig-
ure 2c). After combining the results of both protocols, a
total of 20 true positives out of a possible 24 (83%)
kinase-substrate interactions could be observed on pro-
tein arrays.
Effect of array protein concentration
In the high throughput process employed to generate
thousands of proteins for the high-density protein micro-
arrays, different proteins can vary up to two logs in the
amount of protein that gets deposited on the array. In
Substrate phosphorylation by protein kinases on ProtoArray® Figure 2
Substrate phosphorylation by protein kinases on ProtoArray®. (a) Examples of substrate phosphorylations on protein 
microarrays in the presence of p38alpha and ROKII kinases. (b) Solution validation of commercial kinase substrate pairs. Square 
box indicates substrate phosphorylation by corresponding kinase. (c) Comparison of different kinase buffers on substrate phos-
phorylation., Phosphorylation of inactive p38alpha by MKK6 was observed only in Buffer system I (BSA). Tau protein was phos-
phorylated by PKA to a greater degree in Buffer System II (BSA-free). Net signal was determined by calculating a ratio for the 
[Kinase-ATP only]BufferI/[Kinase-ATP only]BufferII (d) Venn diagram of substrates phosphorylated by kinases in different buffer 
systems.
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order to examine the effect of this variation on the sensi-
tivity of the kinase substrate profiling assay, protein sub-
strates were spotted in a gradient of concentrations from a
maximal solution concentration of approximately 10 μM
to a minimum of 10 pM. Kinase-substrate assays were per-
formed with the 16 protein kinase substrates using both
the BSA and BSA-free protocols. A lower limit of detection
was calculated for each kinase-substrate interaction for
each protocol by defining the minimum amount of pro-
tein (relative solution concentration) spotted that is
required to observe significant signals on the arrays. For
10 of the 16 kinase-substrate interactions, the lower limits
of detection varied only four-fold when comparing the
BSA and BSA-free protocols (Figure 3a). Figure 3b shows
an example of the protein concentration dependent phos-
phorylation of ATF2 by p38 alpha. The lower limit of
detection for the p38 alpha-ATF2 interaction was esti-
mated to be about 10 nM. Interestingly, for six kinase-sub-
strate interaction pairs, the observed lower limits of
detection differed by 30–2000-fold depending on
whether BSA was present in the assay. For example, the
lower limit of detection for the phosphorylation of Tau by
PKA was approximately 2 μM in the presence of BSA, but
was only 0.5 nM when the BSA-free protocol was
employed. In contrast, the lower limit of detection for the
phosphorylation of p38 alpha was 2 μM for the BSA-free
protocol, yet only 23 nM in the presence of BSA. Thus,
both the amount of protein spotted and the presence of
BSA in the assay can influence the sensitivity of the assay
and the ability to observe substrate phosphorylation.
Effect of Time and ATP Concentration
It was of interest to determine whether the sensitivity of
the assay could be further improved by varying other assay
conditions. Two protein kinases, JNK1 and p38 alpha
(MKK14) (Table 1), were incubated on arrays at 30°C for
0, 1, 10, 30, 60 or 120 minute prior to washing and detec-
tion. As shown in Figure 4a, signals for each kinase-sub-
strate interaction were greatest on average at 30–60
minutes following addition of the kinase. At 120 minutes,
net phosphorylation signals of c-Jun and Elk-1 by JNK1
were decreased relative to the 30 and 60 minute time
points due to an increase in background on the protein
array (Figure 4a).
The protein microarray assay exclusively uses radiolabeled
ATP (33Pγ-ATP) at a relatively low concentration (33 nM)
compared to most kinase-substrate phosphorylation
assays, which typically utilize micromolar quantities of
ATP. The KM for most protein kinases is approximately 50
micromolar, raising the possibility that the enzymatic effi-
ciency of the array assays at 33 nM ATP may not be opti-
mal. However, when 0.45, 4.5 or 45 μM unlableled ATP
was added to the p38 alpha kinase array assay, thereby
providing approximately a 10-, 100-, or 1000-fold excess
of unlabeled ATP, a concentration-dependent decrease in
Assay sensitivity Figure 3
Assay sensitivity. (a) The limit of detection (LOD) of each kinase-substrate pair in both buffer systems using ≥ = 3× STDEV 
of the negative control (GST) as a threshold. (b) Images and quantitation of ATF2 by p38alpha.
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signal was observed for both the positive control protein
kinases and the substrates (Figure 4b).
Assay Reproducibility
The reproducibility of the method was determined from
triplicate kinase assays of 50 nM CaMKII in the presence
of the cofactors calcium and calmodulin on protein
microarrays containing 3019 different human proteins
printed in duplicate and a total of 6244 accessory features
(control proteins and buffer/no protein spots). BSA was
included in the assay as described above. Pairwise com-
parisons of background-corrected protein spot signals (n
= 6044) were linearly correlated throughout the signal
range with slopes ranging from 1.17 – 0.90, and with R2
correlation coefficients calculated between 0.92 and 0.96
(Figure 5a). Background-corrected human protein spot
signals were averaged for duplicate spots on a single array,
and Z-Score transformed such that the distribution of
human protein spots within an assay was centered with a
mean of zero and a standard deviation of 1. Thus, a Z-
Score of 3 indicates a phosphorylation signal exactly three
standard deviations above the mean value for the human
protein signals. In this experiment, phosphorylation of a
human protein by CaMKII was considered significant if
the human protein Z-Score was equal or greater than 3,
the duplicate spots coefficient of variation less than 0.5,
and the background-corrected signal in a CaMKII assay
was at least 150% of the background-corrected signal in
the no kinase control assay. Fifty-two human proteins
were found to be significant in at least one of the three
CaMKII assays, but not in the CaMKII-free control assay
(Figure 5b). In general, proteins significant in all three
CaMKII assays had the highest signals, followed by pro-
teins present in two assays, and then by proteins signifi-
cant in a single assay. For 94% of the proteins identified,
the Z-score in the no kinase control assay was below 1.
Among the 52 proteins, 32 were expressed and purified
for validation in solution-based assays. Twenty-three of
the 32 putative substrates identified on the array were also
phosphorylated by CaMKII in solution (See Additional
file 1).
Substrate Identification on High Content Protein Arrays
The yeast proteome microarrays used to map the yeast
phosphorylome were generated through a process involv-
ing high throughput protein expression and purification
using affinity chromatography. The output of this process
is thousands of functional proteins that are greater than
90% pure (data not shown). More recently, this process
has been applied to commercial protein microarray prod-
ucts (ProtoArray® technology) containing thousands of
individually purified human proteins [14]. Many of the
proteins used to manufacture the yeast and human pro-
tein microarrays (See Methods) are phosphorylated dur-
ing expression (data not shown). This raises the
possibility that the endogenous protein phosphorylation
Effect of time and ATP concentration on assay performance Figure 4
Effect of time and ATP concentration on assay performance. (a)Time course of phosphorylation observed for two 
substrates of JNK1 kinase. The net P33 signals were plotted. (b) Different amounts of non radioactive ATP (cATP) were added 
to the reaction mixture and compared to assays with a constant amount of radioactive ATP (γ33P-ATP). The P33 signals (aver-
age from two slides) of different substrates are compared for different amounts of cATP.
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could interfere with protein kinase substrate phosphoryla-
tion on protein arrays by masking phosphorylation sites.
To investigate this further, proteins on the array were
dephosphorylated using a general protein phosphatase
and then incubated with Casein Kinase II (CK2). The level
of phosphoprotein content on the protein arrays was
monitored by probing the arrays with a fluorescent stain
(Pro-Q Diamond) that binds to phosphoamino acids
(Figure 6) [18]. Interestingly, nine proteins on a ProtoAr-
ray®  Human Protein Microarray v1.0 containing over
2,000 human proteins produced significant signals only
after phosphatase treatment (Figure 6a). Seventeen pro-
teins produced significant signals without phosphatase
treatment. The substrate phosphorylation observed on the
array was validated by performing solution assays which
demonstrated that dephosphorylation of the substrates
resulted in enhanced levels of protein phosphorylation
for OSR1 [GenBank: BC008726.1], NRBP [RefSeq:
NM_013392.1] and C10orf7 [GenBank: BC001600.1]
(Figure 6c). Both OSR1 and NRBP are known phospho-
proteins [19,20].
A pooling-deconvolution strategy for substrate 
identification
Recently, an approach was described to improve the effi-
ciency and accuracy of large scale screening experiments
in which pools of potential interactors are applied against
a defined library and then an algorithm is used to decon-
volute the results [21]. This strategy was applied to yeast
two-hybrid and small molecule/cell survival screens and
subsequently validated using protein arrays. In the valida-
tion study, protein-protein interaction assays were per-
formed using pools of proteins probed against yeast
protein microarrays comprised of more than 4000 yeast
proteins, followed by successful deconvolution of
expected individual interaction pairs.
The results presented here extend this work by demon-
strating that a pooling/deconvolution strategy can also be
used with protein kinases to identify specific protein
kinase substrates on high content protein arrays. Four
unique pools of protein kinases were prepared (Figure 7a)
that contained up to three protein kinases in each pool.
Identification of CAMK2 substrates on high content Human ProtoArray® Figure 5
Identification of CAMK2 substrates on high content Human ProtoArray®. (a and b) Scatterplots showing reproduc-
ibility in replicate assays. (c) Venn overlap of CAMK2 substrates identified from triplicate assays.
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Each pooled mixture of kinases was then added separately
to a high content human protein microarray. Multiple
phosphorylation events were observed on each array (data
not shown). The signals for six of the phosphorylated pro-
teins are shown in Figure 7b. These images show that the
signal for each protein substrate varied depending on the
kinase pool added to the array; for example, significant
signals were only observed for CRKL in pools 1 and 3 (Fig-
ure 7b/c). When the pattern of significant signals was
compared to the composition of protein kinases in the
pools, it could be seen that Abl was the only protein
kinase that is present in pools 1 and 3 and absent in pools
2 and 4; thus allowing definitive identification of Abl as
the kinase responsible for CRKL phosphorylation. The
same process was applied to the other substrates to iden-
tify specific kinase-substrate interactions for 6 of the 7
protein kinases (Figure 7c). The decoded protein kinase-
substrate interactions were consistent with data obtained
from arrays treated with single protein kinases (See Addi-
tional file 2).
Conclusion
Posttranslational modification of proteins is one of the
principle regulatory mechanisms in eukaryotes. In partic-
ular, protein phosphorylation has been demonstrated to
be crucial in the proper regulation of nearly all cellular
processes, including metabolism, cell organization and
differentiation, responses to environmental stimuli and
cell-cell interactions. Nevertheless, a thorough under-
standing of the full range of phosphoproteins modified by
Effect of phosphatase pre-treatment on kinase phosphorylation of proteins on microarrays Figure 6
Effect of phosphatase pre-treatment on kinase phosphorylation of proteins on microarrays. (a) CK2 substrates 
identified on phosphatase pre-treated high-content Human ProtoArray® 4. (b) Decrease in phosphate levels of protein micro-
arrays treated with lambda protein phosphatase (LPP) followed by staining with Pro-Q Diamond. (c) Solution validation of CK2 
substrates identified after LPP treatment.
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a specific protein kinase is often lacking. Proteome micro-
arrays have been described in which sets of proteins, or
nearly every protein in the case of yeast, were expressed,
purified, and deposited on a surface in an addressable for-
mat [22-24]. Using such a proteome-scale microarray, Pta-
cek et al created a map of the yeast phosphorylome by
incubating the arrays with nearly every yeast kinase and
identifying thousands of phosphorylation events [14].
These studies revealed a plethora of potentially novel bio-
logical functions as well as new regulatory interactions for
a spectrum of kinases. More recently, a human protein
array was used to identify a novel substrate for Arg and Abl
kinases, the targets of the anti-cancer drug Gleevec [15]. In
the present study, we performed a detailed characteriza-
tion of the ProtoArray® technology as employed to define
kinase-substrate interactions, and have identified a
number of key features that can impact kinase-substrate
discovery efforts.
The first task was to benchmark performance of the
kinase-substrate application on protein arrays relative to
standard solution-based assays. This was accomplished by
defining a test set of kinase-substrate pairs and determin-
ing the correlation of substrate phosphorylation on the
array relative to a solution assay. Twenty out of 24 (83%)
kinase-substrate pairs were reconstituted on arrays, dem-
onstrating that substrate phosphorylation on protein
arrays is highly consistent with solution-based methods,
even under the relatively generic conditions employed in
these assays. Several possibilities exist for the inability to
observe phosphorylation of four protein on the arrays
including (1) binding of the protein to the array surface in
such as way as to preferentially mask a phosphorylation
site; (2) denaturing of the protein on the array that abol-
ishes a kinase interaction domain; (3) altered kinetics of
the phosphorylation reaction on the array surface; or (4)
a combination of several of these factors. Nevertheless,
this "false-negative" rate must be considered in light of the
advantages of the array format including speed, low mate-
rial requirements, and the ability to survey thousands of
purified proteins in a single experiment.
Use of Pooling-Deconvolution for kinase substrate identification on protein microarrays Figure 7
Use of Pooling-Deconvolution for kinase substrate identification on protein microarrays. (a) Composition of 
kinase pools used in assays (b) Representative images of substrate phosphorylations on arrays show how the pooling scheme 
can be used to assign specific substrates to their corresponding kinases. (c) Decoding of kinases responsible for substrate phos-
phorylation.
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In a second set of experiments, we investigated the effect
of assay conditions – specifically, the presence or absence
of BSA in the assay buffer – on the results obtained with
the arrays. Interestingly, 75% of the proteins phosphor-
ylated in solution were observed to be phosphorylated on
the arrays either in the presence or absence of BSA; how-
ever, the substrates identified under the different condi-
tions did not completely overlap. A subset of protein
substrates were observed only in the presence of BSA,
while others were only seen to be phosphorylated on the
array in the absence of BSA. In the former case, BSA may
be stimulating substrate phosphorylation through a
'crowding' effect by increasing the effective local concen-
tration of protein kinase at the array surface. In the latter
case, BSA may be interfering with substrate phosphoryla-
tion through either binding to protein kinases, and/or by
being a substrate for the kinase itself, thereby lowering the
amount of available 33Pγ-ATP and/or kinase in the assay
below the threshold required to give adequate phosphor-
ylation of the substrate. Assays in which BSA was included
in the buffer gave rise to a higher mean Z-Score across the
test set of 24 kinase-substrate pairs, with 17 of the 24 pairs
resulting in higher Z-Scores when BSA was present in the
assay buffer. Based on this result, BSA-containing buffers
are recommended if a single assay condition is to be
employed. Further investigation will be required to deter-
mine the exact mechanism of the effect of BSA in this
assay, and carrying out assays under both assay conditions
should be considered in order to maximize the probabil-
ity of observing substrate phosphorylation.
The study investigating the yeast phosphorylome reported
that approximately two-thirds of previously annotated
phosphorylation events were not observed in their pro-
tein array experiments. One possible explanation for this
observation is that the amount of protein spotted on the
array was too low to be phosphorylated by kinase. To
explore this issue, we measured the relative amount of
protein that must be spotted on the arrays for significant
phosphorylation to be observed, and determined that the
median LOD for the test set of kinase-substrate interactors
was approximately 2 ng/μL, which is equivalent to
approximately 2 pg of spotted protein. The median level
of proteins on the yeast and human proteome arrays are
approximately four-fold greater than this amount, sug-
gesting that the majority of proteins on the arrays are
present in quantities sufficient to observe phosphoryla-
tion. It should also be noted that this amount of spotted
protein is approximately 1000-fold less protein than is
required to observe phosphorylation in a solution-based
assay.
Another factor that could influence the identification of
proteins on the array as substrates for exogenous kinases
could be masking of potential phosphorylation sites as a
result of phosphorylation occurring during protein pro-
duction by endogenous kinases. Using both anti-phos-
phoamino acid antibodies and phosphoamino acid stains
such as ProQ Diamond, we have shown that many yeast
and human proteins expressed from either yeast or insect
cells and spotted on protein arrays are indeed phosphor-
ylated (data not shown). As shown in Figure 6, CK2 phos-
phorylated several proteins only after dephosphorylation
of proteins on the array with lambda protein phos-
phatase. For some proteins, the removal of the phosphate
groups through enzymatic treatment with phosphatase
was required in order to observe substrate phosphoryla-
tion on the array. It should also be pointed out that phos-
phorylation by some kinases may require that substrates
are pre-phosphorylated or "primed" on specific residues.
We have provided further evidence that high content
human protein arrays can be used to make novel insights
into the biology of human protein kinases. In one exam-
ple, 23 substrates were identified and validated for
CamK2, 11 of which could be assigned to specific func-
tions or pathways. The two protein substrates exhibiting
the strongest signals were Doublecortin (DCX) transcript
variants 4 and 2. Doublecortin, which has not previously
been reported as a CAMK2 subsrate, is important for neu-
rite outgrowth in the developing brain, and acts by stabi-
lizing microtubules [25]. The observation that that
calmodulin-kinase 2 phosphorylates doublecortin sug-
gests a mechanism by which CamK2 regulates neuronal
migration by influencing microtubule stability, and is
consistent with the well established role for CamK2 in
neuroplasticity [26,27].
We have also demonstrated for the first time that a pool-
ing-deconvolution strategy can be applied to protein
kinase substrate identification on protein arrays. In these
experiments, four protein substrates were identified
(FLJ22795, SH3YL1, CRKL, ABI1) that were uniquely
phosphorylated on arrays treated with the Abl protein
kinase. Signaling through Abl is critical to regulation of
several cellular functions including organization of the
actin cytoskeleton [28]. CRKL is a known substrate of Abl
[29], and ABI1 is a known Abl interacting protein that has
been shown to facilitate phosphorylation of Mena, a pro-
tein involved in cell adhesion and motility [30]. The pro-
tein SH3YL1 is homologous to the yeast protein Ysc84,
which localizes to the cortical cytoskeleton in yeast and is
involved in coupling endocytosis to the actin network
[31]. This type of data argues that bona fide interactors can
quickly be identified from screens on protein arrays. How-
ever, it is likely that a subset of proteins identified from
such screens will not validate in vivo as protein kinase sub-
strates, particularly if kinase and substrate occupy separate
subcellular compartments. In addition, various factors in
the in vitro array assay, such as kinase and/or substrateBMC Biotechnology 2008, 8:22 http://www.biomedcentral.com/1472-6750/8/22
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concentration, cofactors or lack thereof, or ionic condi-
tions, may lead to inappropriate phosphorylation events.
Finally, it is likely that many membrane-associated pro-
teins, especially those which have regions that span the
membrane, do not exhibit a native conformation on the
array due to the lack of lipid, and thus may be phosphor-
ylated in regions that are normally not accessible to a
kinase. Assimilation of protein microarray data with
orthogonal data types such as protein expression, localiza-
tion, and interaction networks will most certainly enrich
inventories of in vitro kinase-substrate pairs and expand
our understanding of protein kinases function in cellular
processes. We believe such integrated datasets will provide
novel insights to intracellular phosphoprotein signaling
which could ultimately foster important new efforts for
drug discovery and development.
Methods
Protein Arrays
Commerical protein substrates were purchases from Cell
Signalling, Upstate, Calbiochem and Invitrogen. Com-
mercial protein kinases were purchased from Upstate and
Invitrogen. All clones used to generate the human protein
collection were fully sequenced and subcloned into the
expression vector, pDEST™20 (Invitrogen Corp.). These
clones were then used to express proteins in Sf9 insect
cells as N-terminal GST-fusions using the Bac-to-Bac® Bac-
ulovirus Expression System (Invitrogen Corp). Insect cell
lysates were loaded directly into 96-well plates containing
glutathione resin (GE Healthcare). After washing, proteins
were eluted under non-denaturing conditions by the addi-
tion of 10 mM glutathione. ProtoArray® Human Protein
Microarrays v1.0 (Invitrogen Corp., Carlsbad, CA) were
printed on 1 × 3 inch modified glass slides using a 48 pin
contact arrayer (OmniGrid, Genomics Solutions). Protein
arrays were stored at -20°C until use.
Solution kinase assay
10 μl reaction mixtures contained assay buffer II (BSA-
free) (1% Brij35, 100 mM MOPS pH 7.2, 100 mM NaCl,
5 mM MgCl2, 5 mM MnCl2, 1 mM DTT), 33Pγ-ATP (33
nM, 1 μCi/μl), substrate (10–100 ng), and kinase (1–50
nM). Assays were incubated at 30°C for 1 hour and termi-
nated by the addition of 10 μl 2× SDS NuPAGE® Sample
Buffer. Proteins were denatured in a 95°C water bath for
10 minute. 20 μl of samples were loaded into NuPAGE®
10% precast gels. Electrophoresis was performed on the
gels at 120 V for 1 hour. The gels were fixed in 10% acetic
acid and 45% methanol for 45 minutes at RT, then
washed twice with ddH2O for 30 minutes. Gels were
encased in Saran Wrap and transferred to film cassette
containing a phosphorimager screen to detect 33P activity
at room temperature overnight.
Kinase Substrate Identification (KSI) microarray assay
For Buffer System I (BSA), the blocking buffer was 1% BSA
in PBS, and the kinase reaction buffer contained 1% BSA,
1% NP-40, 100 mM MOPS pH 7.2, 100 mM NaCl, 5 mM
MgCl2, 5 mM MnCl2, 1 mM DTT. For Buffer System II
(BSA-free), the blocking buffer contained 50 mM Tris pH
7.5, 0.1% Brij35, and 5 mM MgSO4, and the kinase reac-
tion buffer contained 1% Brij35, 100 mM MOPS pH 7.2,
100 mM NaCl, 5 mM MgCl2, 5 mM MnCl2, 1 mM DTT.
Protein microarrays were blocked for 2 hours in blocking
buffer. 120 μl of kinase reaction mixture containing γ33P-
ATP (1 μCi/μl) and kinase (1–50 nM) was added to the
surface of the microarrays. Arrays were covered with a
Hyperslip™ coverslip, placed into a 50 ml cubicle tube,
and transferred to a 30°C incubator with the array face up.
After 60 minutes incubation, arrays were washed twice
with 0.5% SDS and then twice with distilled water. After
washing, arrays were placed into a 25-slide holder and
spun for 2 minutes at 2000 rpm in a plate centrifuge. Dry
arrays were exposed overnight to a phosphorimager
screen and images were analyzed by the Genepix software
and further analyzed using Microsoft Excel software or
Prospector (Invitrogen). Three independent samples of 50
nM CaMKII and 33 nM γ33P-ATP in Buffer System I were
prepared and incubated on arrays, alongside a single neg-
ative control assay lacking kinase. A second set of three
independent samples of 50 nM CaMKII and 33 nM γ33P-
ATP in the presence of 5 mM CaCl2 and 600 nM calmod-
ulin, in Buffer System I was prepared and incubated on
arrays, alongside a single negative control assay lacking
kinase. For pooling-deconvolution assays, kinase pools
were prepared in Buffer System I.
Phosphatase treatment of the protein microarray
The phosphatase reaction mix contained 400 Unit/ml of
lambda protein phosphatase (New England Biolabs), 50
mM Tris-HCl pH7.5, 0.1 Na2EDTA, 5 mM DTT and 0.01%
Brij35. 120 μl of phosphatase reaction mixture was added
to the surface of the microarrays. Arrays were covered with
a Hyperslip™ coverslip, placed into a 50 ml cubicle tube,
and transferred to a 30°C incubator with the array face up
for 2 hours. Arrays then proceeded to the KSI microarray
assay or the Pro-Q microarray staining assay.
Pro-Q microarray staining
Microarrays were blocked in 1% BSA, 50 mM HEPES pH
7.5, 200 mM NaCl, 0.1% Triton X-100, 25% glycerol, 20
mM reduced glutathione, 0.5 mM DTT at 4°C for 2 hours.
Arrays were placed into a 25 slide holder and spun at 4000
rpm for 2 minutes to remove excess liquid from the slide
surface. Immediately, 120 μl of Pro-Q Diamond™ phos-
phoprotein/phosphopeptide microarray stain was added
to the surface of the microarrays. Arrays were covered with
a Hyperslip™ coverslip, placed into a 50 ml cubicle tube,
and incubated for 30°C at RT with array face up. ArraysBMC Biotechnology 2008, 8:22 http://www.biomedcentral.com/1472-6750/8/22
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were washed with Pro-Q Diamond microarray-destaining
solution twice for 15 minutes and then washed with water
twice for 15 minutes. After washing, arrays were placed
into a 25-slide holder and spun 2 minutes at 2000 rpm in
a plate centrifuge to dry. Dry arrays were scanned with an
Axon Scanner using the 535 nm wavelength setting, 100%
Laser Power, and 600 PMT. Images were analyzed by the
Genepix software and further analyzed using Protoarray™
Prospector (Invitrogen).
Data analysis
Low content arrays: Negative GST control signals were
used to determine background signals for each subarray.
For each spot, the mean background value was subtracted
from the signal for spots in each subarray. Background-
corrected signals were called significant when they were
greater than three times the standard deviation of the aver-
age background signal in the same subarray. High content
arrays: Arrays were analyzed in ProtoArray Prospector 3.0,
including the signal scatter correction feature, and back-
ground signal normalization performed per subarray
from the signal mean from GST and buffer spots.
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